AKT1 and Hepatic fibrosis: In addition, the inhibition of the PI3K/AKT pathway accelerates the synthesis and degradation of ECM in the liver [22], significantly reduces carbon tetrachloride (CCl4)-induced collagen secretion, and improves liver fibrosis in mice [23,24].